Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma

Published:2021-08-28 Issue:5 Volume:107 Page:529-542
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Straka Christian¹^ORCID,Salwender Hans²,Knop Stefan³,Vogel Martin⁴,Müller Jürgen⁵,Metzner Bernd⁶,Langer Christian⁷,Sayer Herbert⁸,Jung Wolfram⁹,Dürk Heinz A.¹⁰,Bassermann Florian¹¹,Gramatzki Martin¹²,Rösler Wolf¹³,Wolf Hans‐Heinrich¹⁴,Brugger Wolfram¹⁵,Engelhardt Monika¹⁶^ORCID,Fischer Thomas¹⁷,Liebisch Peter⁷,Einsele Hermann³

Affiliation:

1. Medizinische Klinik München Klinik Schwabing Munich Germany

2. Asklepios Tumorzentrum AK Altona und AK St. Georg Hamburg Germany

3. Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II Würzburg Germany

4. Janssen‐Cilag GmbH Neuss Germany

5. acromion GmbH Frechen Germany

6. Universitätsklinik für Innere Medizin II Oldenburg Germany

7. Universitätsklinikum Ulm, Klinik für Innere Medizin II Ulm Germany

8. Universitätsklinikum Jena, Klinik für Innere Medizin II Jena Germany

9. Universitätsmedizin Göttingen Göttingen Germany

10. St. Barbara‐Klinik Hamm Germany

11. Klinikum rechts der Isar der Technischen Universität München Munich Germany

12. Universitätsklinikum Schleswig‐Holstein Kiel Germany

13. Universitätsklinikum Erlangen Erlangen Germany

14. Universitätsklinikum Halle Halle (Saale) Germany

15. Schwarzwald‐Baar Klinikum Villingen‐Schwenningen Germany

16. Universitätsklinikum Freiburg Freiburg Germany

17. Universitätsklinikum Magdeburg Magdeburg Germany

Funder

Janssen Pharmaceuticals

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13690

Reference43 articles.

1. NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020

2. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial

4. Multiple myeloma treated with high dose intravenous melphalan

5. Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation;International Journal of Molecular Sciences;2024-07-22

2. Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma: a systematic review and meta-analysis;Hematology;2024-04-23

3. Tandem Autologous Stem Cell Transplantation Improve Outcomes in Multiple Myeloma Patients with high risk factors: A Systematic Review and Meta-Analysis;2023-09-29

4. Conditioning with melphalan 200 mg/m ² and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care;European Journal of Haematology;2022-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3